GNG13 antibody (N-Term)
Quick Overview for GNG13 antibody (N-Term) (ABIN6262017)
Target
See all GNG13 (GNg13) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- GNG13 Antibody detects endogenous levels of total GNG13.
-
Predicted Reactivity
- Pig,Bovine,Horse,Sheep,Dog,Xenopus
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human GNG13, corresponding to a region within N-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:1000-3000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Expiry Date
- 12 months
-
-
- GNG13 (GNg13) (G Protein gamma 13 (GNg13))
-
Alternative Name
- GNG13
-
Background
-
Description: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.
Gene: GNG13
-
Molecular Weight
- 8 kDa
-
Gene ID
- 51764
-
UniProt
- Q9P2W3
-
Pathways
- Peptide Hormone Metabolism, Myometrial Relaxation and Contraction
Target
-